Hostname: page-component-74656f9884-kv2lp Total loading time: 0 Render date: 2026-11-06T03:16:40.641Z Has data issue: false hasContentIssue false

Characterization and in vitro evaluation of gelatin–chitosan scaffold reinforced with bioceramic nanoparticles for bone tissue engineering

Published online by Cambridge University Press:  27 May 2019

Kanchan Maji
Affiliation:
Department of Ceramic Engineering, National Institute of Technology, Rourkela, Odisha 769008, India
Sudip Dasgupta*
Affiliation:
Department of Ceramic Engineering, National Institute of Technology, Rourkela, Odisha 769008, India
*
a)Address all correspondence to this author. e-mail: dasguptas@nitrkl.ac.in

Abstract

Gelatin–chitosan–based scaffolds using different bioactive nano-ceramic phase such as hydroxyapatite (HAp), beta tri calcium phosphate (β-TCP) and 58 s bioactive glass (58 s BG) were fabricated at a fixed 30 wt% of bioceramic phase content. From FTIR spectrum of the composite scaffold, a red shift in amide I and amide II bonds from 1595 to 1545 cm−1 and a new absorption peak due to electrostatic interaction between Ca2+ and COO− were observed. Average pore size in all the composite scaffolds was in the range between 100 and 300 μm, significantly smaller than the average pore size of pure gelatin–chitosan scaffold. Gelatin–chitosan-58 s BG (GCB30) scaffold exhibited the highest amount of protein absorption of 23 mg/cm2 among all the prepared scaffolds after 36 h of incubation in bovine serum albumin (BSA) solution. Mesenchymal stem cell’s (MSC’s) proliferation onto GCB30 scaffold was significantly higher as compared to other prepared scaffolds up to 7 days of cell culture. Expression of both early marker (RUNX2) and late marker (Osteocalcin) of differentiation was higher in MSCs cultured onto GCB30 scaffold as compared to other prepared scaffolds.

Information

Type
Article
Copyright
Copyright © Materials Research Society 2019 
Figure 0

Figure 1: (a) XRD pattern of GCB30, GCT30, and GCH30 scaffold prepared using freeze-drying technique. (b) FTIR-ATR analysis of GCB30, GCT30, and GCH30 scaffold, analyzed in the 500–4000 cm−1 regions.

Figure 1

Figure 2: FESEM micrographs of cross-section of scaffolds (a) GC (b) GCH30 (c) GCT30 (d) GCB30. EDX analysis of respective prepared scaffold.

Figure 2

TABLE I: Average pore diameter of prepared scaffolds using SEM analysis.

Figure 3

Figure 3: 2D and 3D images of GCH 30, GCT30, and GCB30 scaffolds acquired from micro-CT scanning.

Figure 4

TABLE II: Measurement of porosities in the prepared scaffolds by micro-CT scan.

Figure 5

Figure 4: (a) BSA protein uptake by different composite scaffolds (b) UV visible spectrum of BSA in supernatant solution after its adsorption onto different composite scaffolds after 36 h of study.

Figure 6

Figure 5: Degradation kinetics of GC, GCT30, GCB30, and GCH30 scaffolds. Data represent mean value of three independent experiments.

Figure 7

Figure 6: Field emission scanning electron microscope (FESEM) images of human mesenchymal stem cells (hMSCs) grown on (a) GC, (b) GCH30, (c) GCT30, and (d) GCB30 scaffolds after 7 and 14 days.

Figure 8

Figure 7: MTT assay for proliferation of MSCs cultured in osteogenic medium at various periods of cell culture at 3, 5 and 7, 14 days, onto GC, GCH30, GCT30, and GCB30 scaffold. Error bars represent means ± SD for n = 3. *P < 0.05, **P < 0.01.

Figure 9

Figure 8: (I) Images of amplified cDNA products using GAPDH as control for hMSCs cultured on GC, GCH30, GCT30, and GCB30 composite scaffolds in osteogenic media for 7 and 14 days. (II) Quantitative analysis of osteogenic markers up to 14 days on composite scaffold of (a) RUNX2, (b) COL I (c) osteocalcin (d) OPN expression of MSCs cultured on scaffolds by Q-PCR. *Represents statistically significant difference (P < 0.05).

Supplementary material: PDF

Maji and Dasgupta supplementary material

Table S1

Download Maji and Dasgupta supplementary material(PDF)
PDF 130.8 KB